Ozark Health Ventures, LLC dba Cancer Research for the Ozarks

Ozark Health Ventures, LLC dba 奥扎克癌症研究

• 批准号: 8292232
• 负责人: Robert L. Carolla
• 金额: $ 73.11万
• 依托单位: OZARK HEALTH VENTURES, LLC
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-08-15 至 2014-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8292232
• 关键词: African American; Area; Asian Americans; Awareness; Cancer Control; Cancer Prevention Trial; Cancer Research Project; Clinical Trials; Commit; Communities; Community Clinical Oncology Program; Controlled Study; Data; Development; Enrollment; Event; Feedback; Future; Goals; Grant; Health; Health system; Healthcare Systems; Hispanics; Individual; Instruction; Leadership; Malignant Neoplasms; Marketing; Minority; Minority Groups; Mission; Missouri; Monitor; Native Americans; Nursing Administration Research; Nursing Research; Oncologist; Ozarks; Participant; Patient Participation; Patients; Physicians; Population; Prevention; Primary Health Care; Protocols documentation; Qualifying; Quality of Care; Radiation Oncologist; Recommendation; Recruitment Activity; Registered nurse; Reporting; Research; Research Personnel; Resources; Rural Community; Schedule; Screening for cancer; Screening procedure; Site; Specialist; Surgeon; Team Nursing; Testing; Time; Training; Urologist; Validity and Reliability; anticancer research; base; cancer care; cancer therapy; control trial; meetings; member; oncology; prevent; programs; quality assurance; symposium; therapy development; treatment trial

For over 20 years, Cancer Research for the Ozarks (CRO) has provided NCI-approved clinical trials to the rural communities of Southwestern Missouri and surrounding areas. Through the visionary leadership of physicians Wendall Goodwin, MD and Robert L. Carolla, MD, patients who otherwise would not have access to clinical trials can elect to participate through the Community Clinical Oncology Program. From its inception, CRO has had the support of the two nationally recognized health care systems, CoxHealth and St. John's Health System in Springfield, Missouri. With the later addition of two Joplin affiliates, CRO now provides more than 95 percent of cancer care resources in the area including a physician network of oncologists, radiation oncologists, gynecological oncologists, urologists, surgeons, and primary care specialists. CRO supports the CCOP mission of accelerating development of interventions to prevent and treat cancer by increasing accruals to trials. CRO exceeds five percent patient participation with over 200 patients enrolled to treatment and prevention and control trials each of the past five years. CRO's thirty-three physician investigators actively participate in the program increasing awareness of recent developments in treatment, control and prevention and the overall quality of care in the community. CRO has also successfully increased involvement of minorities enrolling a higher percentage than that of the general cancer population. RELEVANCE (See instructions!: Research is the future of mankind. Cancer Research for the Ozarks offers NCI oncology treatment along with cancer control and prevention trials to Springfield and the surrounding communities. The ultimate goal of participation is to find the cure for cancer.

20多年来，Ozarks癌症研究（CRO）提供了NCI批准的临床试验 到西南部密苏里州和周边地区的农村社区。通过有远见的 领导医生温德尔古德温，医学博士和罗伯特L。Mrsella，MD，否则患者 无法参与临床试验的人可以选择通过社区临床试验 肿瘤学项目。 从一开始，CRO就得到了两个国家认可的医疗保健系统的支持， 考克斯健康和圣约翰卫生系统在斯普林菲尔德，密苏里州。后来又加了两个 Joplin附属公司，CRO现在提供该地区95%以上的癌症护理资源 包括一个由肿瘤学家、放射肿瘤学家、妇科肿瘤学家组成的医生网络， 泌尿科医生、外科医生和初级保健专家。 CRO支持CCOP加快制定干预措施以预防和治疗癌症的使命 增加试验的累积费用。CRO超过5%的患者参与， 在过去五年中，每年都有患者参加治疗和预防及控制试验。 CRO的33名医生研究者积极参与该计划，提高认识 治疗、控制和预防方面的最新发展以及 社区CRO还成功地增加了少数民族的参与， 比一般癌症患者的比例高。 相关性（参见说明！： 研究是人类的未来。奥扎克癌症研究中心沿着提供NCI肿瘤治疗 带着癌症控制和预防试验到斯普林菲尔德和周边社区。最终目标 就是找到治愈癌症的方法